×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1739 Total Publications

Classification of Alzheimer Diagnosis from ADNI Plasma Biomarker Data
Jue Mo,1 Stuart Maudsley, Bronwen Martin, Sana Siddiqui, Huey Cheung, and Calvin A. Johnson
PMID: 25599092 ; PMCID:4295502 ; 2013; Journal ACM Conf Bioinform Comput Biol Biomed Inform (2013); doi:10.1145/2506583.2506637
Consistent 4D Brain Extraction of Serial Brain MR Images
Wang Y1, Li G2, Nie J2, Yap PT2, Guo L3, Shen D2.
PMID: 25089172 ; PMCID:4116794 ; 2013; Journal Proc SPIE Int Soc Opt Eng; doi:10.1117/12.2006651
Diagnostic accuracy of markers for prodromal Alzheimer’s disease in independent clinical series.
Prestia, A., Caroli, A., Herholz, K., Reiman, E., Chen, K., Jagust, W. J., & Frisoni, G. B.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 6; pp. 677-86; doi:10.1016/j.jalz.2012.09.016
Effect of cognitive reserve markers on Alzheimer pathologic progression.
Lo, R. Y., & Jagust, W. J.
2013; Journal Alzheimer's Disease and Associated Disorders; vol. 27; pp. 343-350; doi:10.1097/WAD.0b013e3182900b2b
Improving the convergence rate in affine registration of PET and SPECT brain images using histogram equalization.
Salas-Gonzalez, D., Górriz, J. M., Ramírez, J., Padilla, P., & Illán, I. A.
2013; Journal Computational and Mathematical Methods in Medicine; vol. 760903; doi:10.1155/2013/760903
Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.
Guo, L.-H., Alexopoulos, P., & Perneczky, R.
2013; Journal European Archives of Psychiatry and Clinical Neuroscience; vol. 263; no. 7; pp. 553-60; doi:10.1007/s00406-013-0405-4
Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
Shokouhi, S., Claassen, D., Kang, H., Ding, Z., Rogers, B., Mishra, A., & Riddle, W. R.
2013; Journal Journal of Nuclear Medicine; vol. 54; no. 9; pp. 1564-9; doi:10.2967/jnumed.112.116137
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50; doi:10.1038/nature12415
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94; doi:10.1016/j.nicl.2013.07.005
Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer’s disease.
Mattsson, N., Insel, P., Tosun, D., Zhang, J., Jack Jr., C. R., Galasko, D., … Weiner, M.
2013; Journal PloS One; vol. 8; no. 12; pp. e85443; doi:10.1371/journal.pone.0085443